It is with great pleasure that I extend a warm welcome to you on behalf of the European Liver Patients' Association (ELPA). As the President of ELPA, I am excited to embark on this journey alongside you, as we witness the inception of a groundbreaking project - ARTEMIS. ARTEMIS holds the promise of revolutionizing liver health care, and we eagerly anticipate the results and benefits it will bring to patients. Through this consortium, patients will experience a paradigm shift in their journey towards liver health, with access to innovative solutions and personalized care like never before. At ELPA, we are committed to ensuring that ARTEMIS remains true to its core values of patient- centricity and transparency. We are proud to partner with ARTEMIS, working hand in hand to prioritize the needs and well-being of patients at every stage of the project. As we embark on this journey together, we look forward to witnessing the tangible impact of ARTEMIS on patients' lives. We are insistent on transparency, ensuring that patients have access to clear and accurate information, empowering them to make informed decisions about their health. I extend my gratitude to all the stakeholders involved in making ARTEMIS a reality. Together, we are shaping a future where liver health is prioritized, and patients receive the care and support they deserve. Thank you for your interest in ARTEMIS. Join us as we eagerly await the results and benefits that this innovative project will bring to patients worldwide. We expected to achieve considerable societal impact, by offering clinicians and patients an interactive visualization tool wherein real-world data, as well as risk stratification and early diagnosis predictions are made easy. This is an ambitious project involving 9 countries, 21 partners and a cohort of 7500 patients but ambition is a fundamental ingredient when taking the challenge to improve MASLD patients' hearthcare journy!